ASGR1 and coronary artery disorder: In 2016, a human genetics study by Nioi et al. found that loss-of-function mutations in hepatic asialoglycoprotein receptor 1 (ASGR1) were associated with low levels of circulating cholesterol and a reduced risk of coronary artery disease (CAD) [12].